The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling of renal medullary carcinoma to reveal frequent alterations in chromatin remodeling genes and to identify EZH2 as a relevant therapeutic target.
 
Jianjun Gao
Consulting or Advisory Role - Genentech
 
Gabriel G. Malouf
Honoraria - GlaxoSmithKline; Janssen; Novartis; Roche
Consulting or Advisory Role - Novartis
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Janssen; Novartis; Pfizer
 
Xiaoping Su
No Relationships to Disclose
 
Hui Yao
No Relationships to Disclose
 
Priya Rao
No Relationships to Disclose
 
Rong He
No Relationships to Disclose
 
Liangwen Xiong
No Relationships to Disclose
 
Jose A. Karam
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
 
Surena F. Matin
Consulting or Advisory Role - Theracoat; Tokai Pharmaceuticals
Research Funding - AT&T
 
Roger Mouawad
No Relationships to Disclose
 
Eva Comperat
No Relationships to Disclose
 
David Khayat
Stock and Other Ownership Interests - Agenus
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Celgene; Equatour; genomic health; Laval Sante; SOFIE
 
Christopher G. Wood
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Argos Therapeutics; Boehringer Ingelheim; GlaxoSmithKline; Ono Pharmaceutical; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics
 
Nizar M. Tannir
Honoraria - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis
Research Funding - Bristol-Myers Squibb; Epizyme; Exelixis; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis; Pfizer